The retrospective study focuses on 213 patients at 13 centers with chronic pain who were treated with the system. To date, 140 patients have reached the six months post-implant point.
The study found that there was a reduction in pain from an average baseline score of 7.15, on a 10-point scale, to an average score of 2.93 at the six month mark. In patients with severe back pain, there was a reduction from an average score of 8.78 at baseline to 3.68 at six months post-implant.
More Articles on Devices:
5 Key Results: LDR’s Mobi-C Artificial Disc Replacement vs. ACDF
FDA Clears AccelSPINE’s Next Generation Minimally Invasive Spine System
Global Medical Device Market to Grow at 6.2% Annually Until 2018
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
